Last $43.46 USD
Change Today -2.24 / -4.90%
Volume 534.8K
OVAS On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michelle Dipp M.D., Ph.D.

Co-Founder, Chief Executive Officer and Director, OvaScience, Inc.
AgeTotal Calculated CompensationThis person is connected to 38 board members in 1 different organizations across 2 different industries.

See Board Relationships
38--
As of Fiscal Year 2013

Background*

Dr. Michelle Dipp, M.D., Ph.D. Co-founded OvaScience, Inc. in April 2011 and has been its Chief Executive Officer since June 2011. Dr. Dipp served as President OvaScience, Inc. from September 2011 to December 2014. Dr. Dipp is a Co-Founder of Verastem, Inc., Alnara Pharmaceuticals, and FlexPharma. She is also the Founder and Partner at Longwood Founders Management, LLC. Dr. Dipp served as a Senior Vice President and Head of the CEEDD at GlaxoSmithKline. She served as ...

Read Full Background

Corporate Headquarters*

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-500-2802
Fax: --

Board Members Memberships*

2011-Present
Co-Founder, Chief Executive Officer and Director

Education*

PhD
University of Oxford
MD
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options84,828
Exercisable Options Value$113,670
Unexercisable Options254,485
Unexercisable Options Value$341,010
Total Value of Options$454,679
Total Number of Options339,313

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OVAS:US $43.46 USD -2.24

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OVASCIENCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.